Pregnancy, childbirth, postpartum, and infant health updates and guidance.
CDC and ACOG continue to recommend COVID-19 vaccination during pregnancy in 2026. Here’s what current U.S. guidance says about safety, protection for newborns, timing with other prenatal vaccines, and what remains uncertain.
If you’re 32–36 weeks pregnant during RSV season, a one-time RSV vaccine may help protect your newborn during the highest-risk months. Here’s how it works, how it compares with infant nirsevimab, what the trial data show, and what to consider for the 2025–2026 season.
The CDC’s latest provisional data show that maternal deaths in the United States remain a serious public health concern. Here’s what the newest numbers mean for pregnant and postpartum families, including leading causes, disparities, warning signs, and why insurance coverage after birth matters.
The latest CDC data show that pregnancy-related deaths in the United States remain significantly higher for Black women and some American Indian and Alaska Native women than for White women. Here’s what the numbers mean, why many deaths happen after delivery, and what extended Medicaid coverage may realistically change.
The U.S. Preventive Services Task Force has updated its guidance on screening for iron deficiency anemia. Here’s what the new grades mean for infants, pregnant people, and adults—and how they affect preventive care coverage under federal law.
Federal health officials say the multistate infant botulism outbreak linked to ByHeart formula has ended. Here’s what happened, what symptoms parents should still watch for, and what to do if you have the recalled product at home.
A practical guide for U.S. families on how maternal RSV vaccination during pregnancy and infant nirsevimab are reducing hospitalizations this 2025–2026 respiratory virus season.
After criticism over how infant formula shortages and infant botulism recalls were handled, the FDA says it is strengthening recall oversight, improving communication, and moving faster when infant health is at risk. Here’s what that means for families.
RSV remains a leading cause of hospitalization in U.S. infants, but maternal vaccination and infant immunization are reshaping protection in the 2025–2026 season. Here’s what families should know.
Group B strep is common and usually harmless in adults, but it can cause serious infections in newborns. Here’s what current U.S. guidelines recommend for screening and treatment during pregnancy, what symptoms to watch for in babies, and what researchers are studying next.
End of content
End of content
